| 1 |
Osmani L, Askin F, Gabrielson E, et al. Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy[J]. Semin Cancer Biol, 2018, 52: 103-109.
|
| 2 |
白 莹，马 娟，吕 欣，等. 慢性阻塞性肺疾病合并肺癌临床特征分析[J/CD]. 中华肺部疾病杂志(电子版), 2021, 14(3): 265-271.
|
| 3 |
Coudray N, Ocampo PS, Sakellaropoulos T, et al. Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning[J]. Nat Med, 2018, 24: 1559-1567.
|
| 4 |
Lim SW, Ahn MJ. Current status of immune checkpoint inhibitors in treatment of non-small celllung cancer[J]. Korean J Intern Med, 2019, 34(1): 50- 59.
|
| 5 |
Shehzad A, Islam SU, Shahzad R, et al. Extracellular vesicles in cancer diagnostics and therapeutics[J]. Pharmacol Therapeut, 2021, 223: 107806.
|
| 6 |
Shehzad A, Islam SU, Shahzad R, et al. Extracellular vesicles in cancer diagnostics and therapeutics[J]. Pharmacol Therapeut, 2021: 107806.
|
| 7 |
Paskeh MDA, Entezari M, Mirzaei S, et al. Emerging role of exosomes in cancer progression and tumor microenvironment remodeling[J]. J Hematol Oncol, 2022, 15(1): 83.
|
| 8 |
Skalnikova HK, Bohuslavova B, Turnovcova K, et al. Isolation and Characterization of Small Extracellular Vesicles from Porcine Blood Plasma, Cerebrospinal Fluid, and Seminal Plasma[J]. Proteomes, 2019, 7(2): 17.
|
| 9 |
Logozzi M, Di Raimo R, Mizzoni D, et al. What we know on the potential use of exosomes for nanodelivery[J]. Semin Cancer Biol, 2022, 86(1): 13-25.
|
| 10 |
Stefanius K, Servage K, Orth K. Exosomes in cancer development[J]. Curr Opin Genet Dev, 2021, 66: 83-92.
|
| 11 |
Medeiros T, Myette RL, Almeida JR, et al. Extracellular Vesicles: Cell-Derived Biomarkers of Glomerular and Tubular Injury[J]. Cell Physiol Biochem, 2020, 54(1): 88-109.
|
| 12 |
Wang Y, Zhang H, Wang J, et al. Circular RNA expression profile of lung squamous cell carcinoma: identification of potential biomarkers and therapeutic targets[J]. Biosci Rep, 2020, 40(4): BSR20194512.
|
| 13 |
Salzman J, Chen RE, Olsen MN, et al. Cell-type specific features of circular RNA expression[J]. PLoS Genet, 2013, 9(9): e1003777.
|
| 14 |
Charlesworth A, Meijer HA, De Moor CH. Specificity factors in cytoplasmic polyadenylation[J]. Wiley Interdiscip Rev RNA, 2013, 4(4): 437-461.
|
| 15 |
Zhao R, Peng C, Song C, et al. BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates[J]. Int Immunopharmacol, 2020, 87: 106828.
|
| 16 |
Wang H, Guo Y, Mi N, et al. miR-101-3p and miR-199b-5p promote cell apoptosis in oral cancer by targeting BICC1[J]. Mol Cell Probes, 2020, 52: 101567.
|
| 17 |
Wankhede D. Evaluation of eighth AJCC TNM sage for lungcancer NSCLC: ameta-analysis[J]. Ann Surg Oncol, 2021, 28(1): 142-147.
|
| 18 |
Hessvik NP, Liorente A. Current knowledge on exosome biogenesis and release[J]. Cell Mol Life Sci, 2018, 75: 193-208.
|
| 19 |
Li X, Yang L, Chen LL. The Biogenesis, functions, and challenges of circular RNAs[J]. Mol Cell, 2018, 71: 428-442.
|
| 20 |
Cheng Z, Yu C, Cui S, et al. circTP63 functions as a ceRNA to promote lung squamous cell carcinoma progression by upregulating FOXM1[J]. Nat Commun, 2019, 10(1): 3200.
|
| 21 |
Zhang LX, Gao J, Long X, et al. The circular RNA circHMGB2 drives immunosuppression and anti-PD-1 resistance in lung adenocarcinomas and squamous cell carcinomas via the miR-181a-5p/CARM1 axis[J]. Mol Cancer, 2022, 21(1): 110.
|
| 22 |
Liang Y, Wang N, Zhang Y, et al. Self-restricted circular RNA circSOX2 suppressed the malignant progression in SOX2-amplified LUSC[J]. Cell Death Dis, 2022, 13(10): 873.
|
| 23 |
Paskeh MDA, Entezari M, Mirzaei S, et al. Emerging role of exosomes in cancer progression and tumor microenvironment remodeling[J]. J Hematol Oncol, 2022, 15(1): 83.
|
| 24 |
Medeiros T, Myette RL, Almeida JR, et al. Extracellular vesicles: Cell-derived biomarkers of glomerular and tubular injury[J]. Cell Physiol Biochem, 2020, 54(1): 88-109.
|
| 25 |
Stahl PD, Raposo G. Extracellular vesicles: Exosomes and microvesicles，integrators of homeostasis[J]. Physiology, 2019, 34(3): 169-177.
|
| 26 |
Perez-Boza J, Lion M, Struman I. Exploring the RNA landscape of endothelial exosomes[J]. RNA, 2018, 24: 423-435.
|
| 27 |
Santangelo L, Giurato G, Cicchini C, et al. The RNA-binding protein SYNCRIP is a component of the hepatocyte exosomal machinery controlling microRNA sorting [J]. Cell Rep, 2016, 17: 799-808.
|
| 28 |
Wei H, Chen Q, Lin L, et al. Regulation of exosome production and cargo sorting[J]. Int J Biol Sci, 2021, 17(1): 163-177.
|
| 29 |
Li X, Yang L, Chen LL. The Biogenesis, functions, and challenges of circular RNAs[J]. Mol Cell, 2018, 71(3): 428-442.
|
| 30 |
Wilusz JE. A 360° view of circular RNAs: From biogenesis to functions[J]. Wiley Interdiscip Rev RNA, 2018, 9(4): e1478.
|
| 31 |
Luo Y, Liu F, Ma J, et al. A novel epigenetic regulation of circFoxp1 on Foxp1 in colon cancer cells[J]. Cell Death Dis, 2020, 11(9): 782.
|